首页 › 基金 › Boxer Capital Management, LLC › OCUL
Boxer Capital Management, LLC 对 OCUL 的持仓历史
OCULAR THERAPEUTIX INC · 医疗保健
Boxer Capital Management, LLC 在 Q2 2026 的 13F 申报中披露持有 OCUL(OCULAR THERAPEUTIX INC)1,300,000 股,市值约 US$12.8M,约占其申报组合的 0.96%,在其申报持仓中市值排名第 23 位。 Boxer Capital Management, LLC 最近 2 个申报季度中有 2 个季度披露了 OCUL 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Boxer Capital Management, LLC 对 OCUL 的持仓演变
Boxer Capital Management, LLC 于 Q1 2026 首次披露 OCUL 持仓:350,000 股(约 US$3.0M)。 该持仓在 Q2 2026 达到峰值 1,300,000 股,市值约 US$12.8M。 在 2 次申报中,Boxer Capital Management, LLC 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 1,300,000 股、市值约 US$12.8M,环比增持 950,000 股。。 持仓曾出现大幅变动:Q2 2026 增持约 271% (随后一个季度股价下跌 22%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 350.00K | $2.96M | 新进 |
| Q2 2026 | 1.30M | $12.77M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 OCUL 与 13F 数据
OCUL(OCULAR THERAPEUTIX INC)属于医疗保健行业。我们追踪的基金中还有 42 只申报持有 OCUL,申报仓位最大的包括:Deep Track Capital, LP (US$193.3M), Avoro Capital Advisors LLC (US$123.1M), SUMMER ROAD LLC (US$119.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 OCUL 的基金
- Deep Track Capital, LP 19.69M 股 · $193.32M · Q2 2026
- Avoro Capital Advisors LLC 12.54M 股 · $123.14M · Q2 2026
- SUMMER ROAD LLC 12.21M 股 · $119.89M · Q2 2026
- Venrock Adviser, LLC 10.35M 股 · $101.61M · Q2 2026
- Logos Global Management LP 5.30M 股 · $52.05M · Q2 2026
- DELTEC ASSET MANAGEMENT LLC 2.48M 股 · $24.32M · Q2 2026
- Octagon Capital Advisors LP 2.08M 股 · $20.38M · Q2 2026
- TCG Crossover Management, LLC 1.65M 股 · $16.18M · Q2 2026
- Defilade Capital Management, L.P. 1.49M 股 · $14.63M · Q2 2026
- Knoll Capital Management, LLC 1.15M 股 · $11.30M · Q2 2026
更多关于 Boxer Capital Management, LLC
常见问题
How long has Boxer Capital Management, LLC held OCUL?
Boxer Capital Management, LLC has disclosed OCUL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Boxer Capital Management, LLC's current position in OCUL?
As of Q2 2026, Boxer Capital Management, LLC holds 1.30M shares of OCUL (OCULAR THERAPEUTIX INC), valued at $12.77M, representing 0.96% of its reported portfolio and ranking #23.
Has Boxer Capital Management, LLC been buying or selling OCUL?
In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC increased its position in OCUL. The position peaked in Q2 2026 at 1.30M shares.
Which other funds hold OCUL?
Other major institutional holders of OCUL include Deep Track Capital, LP, Avoro Capital Advisors LLC, SUMMER ROAD LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.